Last updated: 5 September 2024 at 6:12pm EST

Geoffrey Beran Rose Net Worth




The estimated Net Worth of Geoffrey Beran Rose is at least $5.94 million dollars as of 3 September 2024. Mr Rose owns over 4,586 units of Pulmonx Corp stock worth over $2,289,606 and over the last 4 years he sold LUNG stock worth over $3,254,920. In addition, he makes $391,516 as Chief Commercial Officer at Pulmonx Corp.

Mr Rose LUNG stock SEC Form 4 insiders trading

Mr has made over 36 trades of the Pulmonx Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 4,586 units of LUNG stock worth $30,726 on 3 September 2024.

The largest trade he's ever made was exercising 49,428 units of Pulmonx Corp stock on 18 May 2021 worth over $69,199. On average, Mr trades about 5,244 units every 34 days since 2021. As of 3 September 2024 he still owns at least 295,433 units of Pulmonx Corp stock.

You can see the complete history of Mr Rose stock trades at the bottom of the page.





Mr. Geoffrey Beran Rose biography

Geoffrey Beran Rose is the Chief Commercial Officer at Pulmonx Corp.

What is the salary of Mr Rose?

As the Chief Commercial Officer of Pulmonx Corp, the total compensation of Mr Rose at Pulmonx Corp is $391,516. There are 1 executives at Pulmonx Corp getting paid more, with Glendon E. French having the highest compensation of $626,824.



How old is Mr Rose?

Mr Rose is 48, he's been the Chief Commercial Officer of Pulmonx Corp since . There are 3 older and 1 younger executives at Pulmonx Corp. The oldest executive at Pulmonx Corp is David A. Lehman, 60, who is the Gen. Counsel & Sec..

What's Mr Rose's mailing address?

Geoffrey's mailing address filed with the SEC is C/O PULMONX CORPORATION, 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063.

Insiders trading at Pulmonx Corp

Over the last 4 years, insiders at Pulmonx Corp have traded over $195,808,760 worth of Pulmonx Corp stock and bought 107,681 units worth $1,883,657 . The most active insiders traders include Scientific Corp Boston, Thomas William Burns et Glendon E. Iii French. On average, Pulmonx Corp executives and independent directors trade stock every 13 days with the average trade being worth of $393,258. The most recent stock trade was executed by Geoffrey Beran Rose on 3 September 2024, trading 4,586 units of LUNG stock currently worth $30,726.



What does Pulmonx Corp do?

Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.



What does Pulmonx Corp's logo look like?

Pulmonx Corp logo

Complete history of Mr Rose stock trades at Pulmonx Corp

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
3 Sep 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 4,586 $6.70 $30,726
3 Sep 2024
295,433
24 Jun 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $6.16 $7,293
24 Jun 2024
300,019
3 Jun 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 4,297 $6.97 $29,950
3 Jun 2024
301,203
22 May 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $8.71 $10,313
22 May 2024
305,500
22 Apr 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $7.49 $8,868
22 Apr 2024
306,684
22 Mar 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $9.36 $11,082
22 Mar 2024
307,868
1 Mar 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 3,097 $9.06 $28,059
1 Mar 2024
239,952
22 Feb 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $14.20 $16,813
22 Feb 2024
243,049
22 Jan 2024 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $13.13 $15,546
22 Jan 2024
244,233
22 Dec 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $12.75 $15,096
22 Dec 2023
245,417
1 Dec 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 2,868 $10.34 $29,655
1 Dec 2023
246,601
22 Nov 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $10.60 $12,550
22 Nov 2023
249,469
23 Oct 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $8.35 $9,886
23 Oct 2023
250,653
22 Sep 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $10.51 $12,444
22 Sep 2023
251,837
1 Sep 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 2,843 $10.01 $28,458
1 Sep 2023
253,021
23 Aug 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,184 $10.54 $12,479
23 Aug 2023
255,864
1 Jun 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 2,845 $11.48 $32,661
1 Jun 2023
257,048
1 Mar 2023 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,206 $11.03 $13,302
1 Mar 2023
180,993
1 Dec 2022 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,055 $5.93 $6,256
1 Dec 2022
181,037
1 Sep 2022 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,027 $17.89 $18,373
1 Sep 2022
182,092
1 Jun 2022 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 1,011 $18.05 $18,249
1 Jun 2022
183,118
10 Mar 2022 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Exercice d'option 29,427 $2.10 $61,797
10 Mar 2022
184,129
1 Mar 2022 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 426 $25.91 $11,038
1 Mar 2022
123,702
15 Dec 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 22,000 $30.55 $672,100
15 Dec 2021
123,459
1 Dec 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 355 $32.73 $11,619
1 Dec 2021
145,459
15 Nov 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 7,000 $39.94 $279,580
15 Nov 2021
145,814
15 Oct 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 7,000 $39.44 $276,080
15 Oct 2021
152,814
15 Sep 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 7,000 $38.12 $266,840
15 Sep 2021
159,814
1 Sep 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 355 $40.09 $14,232
1 Sep 2021
166,814
16 Aug 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 7,000 $36.71 $256,970
16 Aug 2021
166,885
15 Jul 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 7,000 $38.73 $271,110
15 Jul 2021
173,885
24 May 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 4,797 $40.88 $196,101
24 May 2021
163,285
18 May 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Exercice d'option 49,428 $1.40 $69,199
18 May 2021
166,101
10 May 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 4,797 $40.70 $195,238
10 May 2021
116,673
19 Apr 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 4,797 $43.24 $207,422
19 Apr 2021
121,470
5 Apr 2021 Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
Vente 4,797 $47.64 $228,529
5 Apr 2021
109,064


Pulmonx Corp executives and stock owners

Pulmonx Corp executives and other stock owners filed with the SEC include: